Work

Presentation in Patients With Angiographically Documented Coronary Artery Disease and Type II Diabetes Mellitus (from the BARI 2D Clinical Trial)

Year: 2011

Type: article

Source: The American Journal of Cardiology

DOI: 10.1016/j.amjcard.2011.08.004

Authors: Ashok Krishnaswami, Regina Hardison, Richard W. Nesto, Burton Sobel

Institutions: Kaiser Permanente, Kaiser Permanente San Jose Medical Center, University of Pittsburgh, Lahey Hospital and Medical Center

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Astellas Pharma US, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Novo Nordisk, Astellas Pharma, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1479962227, BARI II - FIBRINOLYSIS AND COAGULATION CORE, G4649726151, G5200799671, ECONOMIC OUTCOMES OF TREATMENT STRATEGIES IN BAR1-2, BARI II: A TRIAL OF REVASC. & GLYCEMIC CONTROL IN NIDDM, BARI II GRANT PROPOSAL FOR ECG CORE LABORATORY

OpenAlex ID: W2106983570

FWCI: 0.429

Cites: 18

Cited by: 16

Related to: 10